Evidence map›Paper›PMID 36708766›Full record

ReviewThe journal of allergy and clinical immunology. In practice2023

Is Your Kid Actin Out? A Series of Six Patients With Inherited Actin-Related Protein 2/3 Complex Subunit 1B Deficiency and Review of the Literature.

Estefanía Vásquez-Echeverri, Marco Antonio Yamazaki-Nakashimada, Edna Venegas Montoya, Selma Cecilia Scheffler Mendoza, Lina Maria Castano-Jaramillo, Edgar Alejandro Medina-Torres, Maria Edith González-Serrano, Melissa Espinosa-Navarro, Juan Carlos Bustamante Ogando, María Guadalupe González-Villarreal and 16 more

Open access · greenAbstract readReview
In one paragraph

Review in The journal of allergy and clinical immunology. In practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 8 institutions in 5 countries.

Estefanía Vásquez-EcheverriImmune Deficiencies Laboratory, National Institute of Pediatrics, Health Secretariat, Mexico City, Mexico.
Marco Antonio Yamazaki-NakashimadaClinical Immunology Service, National Institute of Pediatrics, Health Secretariat, Mexico City, Mexico.
Edna Venegas MontoyaImmunology Service, Unidad Médica de Alta Especialidad, Monterrey, Nuevo Leon, Mexico.
Selma Cecilia Scheffler MendozaClinical Immunology Service, National Institute of Pediatrics, Health Secretariat, Mexico City, Mexico.
Lina Maria Castano-JaramilloClinical Immunology Service, National Institute of Pediatrics, Health Secretariat, Mexico City, Mexico; Fundación Hospital de la Misericordia, Bogotá, Colombia.
Edgar Alejandro Medina-TorresImmune Deficiencies Laboratory, National Institute of Pediatrics, Health Secretariat, Mexico City, Mexico.
Maria Edith González-SerranoImmune Deficiencies Laboratory, National Institute of Pediatrics, Health Secretariat, Mexico City, Mexico.
Melissa Espinosa-NavarroImmune Deficiencies Laboratory, National Institute of Pediatrics, Health Secretariat, Mexico City, Mexico.
Juan Carlos Bustamante OgandoClinical Immunology Service, National Institute of Pediatrics, Health Secretariat, Mexico City, Mexico.
María Guadalupe González-VillarrealHematology Service, Unidad Médica de Alta Especialidad, Monterrey, Nuevo Leon, Mexico.
Margarita Ortega CisnerosAllergy and Clinical Immunology Service, Unidad Médica de Alta Especialidad, Centro Médico Nacional de Occidente IMSS, Guadalajara, Jalisco, Mexico.
Pedro Francisco Valencia MayoralPathology Department, Hospital Infantil de Mexico "Dr Federico Gomez," Mexico City, Mexico.
Alejandra Consuelo SanchezPediatric Gastroenterology and Nutrition Department, Hospital Infantil de Mexico "Dr Federico Gomez," Mexico City, Mexico.
Gustavo Varela-FascinettoTransplantation Department, Hospital Infantil de Mexico "Dr Federico Gomez," Mexico City, Mexico.
Rosa María Nideshda Ramírez-UribeStem Cell Transplantation Unit, National Institute of Pediatrics, Health Secretariat, Mexico City, Mexico.
Yuridia Salazar GálvezImmunology Service, Unidad Médica de Alta Especialidad, Monterrey, Nuevo Leon, Mexico.
Laura Cecilia Bonifaz AlonzoImmunochemistry Research Unit, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, IMSS, Mexico City, Mexico.
Ezequiel Moisés Fuentes-PananáResearch Unit on Virology and Cancer, Hospital Infantil de Mexico "Dr Federico Gomez," Mexico City, Mexico.
Noemí Gómez HernándezAllergy and Clinical Immunology Service, Unidad Médica de Alta Especialidad, Centro Médico Nacional de Occidente IMSS, Guadalajara, Jalisco, Mexico.
César Mauricio Rojas MaruriPathology Department, National Institute of Pediatrics, Health Secretariat, Mexico City, Mexico.
Jean-Laurent CasanovaSt Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York City, NY; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM, Necker Hospital for Sick Children, Paris, France; Imagine Institute, University of Paris, Paris, France; Department of Pediatrics, Necker Hospital for Sick Children, Paris, France; Howard Hughes Medical Institute, Paris, France.
Sara Elva Espinosa-PadillaImmune Deficiencies Laboratory, National Institute of Pediatrics, Health Secretariat, Mexico City, Mexico. Electronic address: saraelvaespino@gmail.com.
Aidé Tamara Staines BooneImmunology Service, Unidad Médica de Alta Especialidad, Monterrey, Nuevo Leon, Mexico. Electronic address: tamarastaines@gmail.com.
Gabriel López-VelázquezLaboratory of Biomolecules and Infant Health, National Institute of Pediatrics, Health Secretariat, Mexico City, Mexico.
Bertrand BoissonSt Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York City, NY; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM, Necker Hospital for Sick Children, Paris, France; Imagine Institute, University of Paris, Paris, France.
Saul Oswaldo Lugo ReyesImmune Deficiencies Laboratory, National Institute of Pediatrics, Health Secretariat, Mexico City, Mexico. Electronic address: dr.lugo.reyes@gmail.com.
Hospital Infantil de México Federico Gómez · MXCentro Medico Nacional Siglo XXI · MXFundación Hospital San Pedro · COHospital de Especialidades · MXHoward Hughes Medical Institute · USInserm · FRSecretaria de Salud · MXVietnam National Children's Hospital · VN

Funding

Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational SuccessUL1TR001866 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY, KRUEGER, JAMES G · 2016 to 2025
$40.6M
Regulation of IgA class switching in the intestinal mucosaP01AI061093 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI CUNNINGHAM-RUNDLES, CHARLOTTE · 2004 to 2021
$29.8M
NCATS NIH HHS UL1 TR001866NIAID NIH HHS P01 AI061093
6 · The paper itself

Abstract

backgroundHereditary actin-related protein 2/3 complex subunit 1B deficiency is characterized clinically by ear, skin, and lung infections, bleeding, eczema, food allergy, asthma, skin vasculitis, colitis, arthritis, short stature, and lymphadenopathy.

objectiveWe aimed to describe the clinical, laboratory, and genetic features of six patients from four Mexican families.

methodsWe performed exome sequencing in patients of four families with suspected actinopathy, collected their data from medical records, and reviewed the literature for reports of other patients with actin-related protein 2/3 complex subunit 1B deficiency.

resultsSix patients from four families were included. All had recurrent infections, mainly bacterial pneumonia, and cellulitis. A total of 67% had eczema whereas 50% had food allergies, failure to thrive, hepatomegaly, and bleeding. Eosinophilia was found in all; 84% had thrombocytopenia, 67% had abnormal-size platelets and anemia. Serum levels of IgG, IgA, and IgE were highly increased in most; IgM was normal or low. T cells were decreased in 67% of patients, whereas B and NK cells were increased in half of patients. Two of the four probands had compound heterozygous variants. One patient was successfully transplanted. We identified 28 other patients whose most prevalent features were eczema, recurrent infections, failure to thrive, bleeding, diarrhea, allergies, vasculitis, eosinophilia, platelet abnormalities, high IgE/IgA, low T cells, and high B cells.

conclusionActin-related protein 2/3 complex subunit 1B deficiency has a variable and heterogeneous clinical spectrum, expanded by these cases to include keloid scars and Epstein-Barr virus chronic hepatitis. A novel deletion in exon 8 was shared by three unrelated families and might be the result of a founder effect.

Indexed as

EczemaEosinophiliaEpstein-Barr Virus InfectionsVasculitisActin-Related Protein 2Actin-Related Protein 3ActinsFailure to ThriveHerpesvirus 4, HumanHumansImmunoglobulin AImmunoglobulin EReinfectionActin-Related Protein 2Actin-Related Protein 3ActinsImmunoglobulin AImmunoglobulin EActinopathyARPC1B deficiencyCombined immune deficiencyCytoskeletonHyper-IgEInborn errors of immunityPrimary immunodeficiencyWhole-exome sequencing

Identifiers

PMID36708766
PMCPMC10085853
OpenAlexW4318015341

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.